Company page

Neximmune, Inc.

Neximmune, Inc. is a public company traded under the ticker NEXI in the American market, with a market capitalization of $139 million. The company focuses on developing innovative immunotherapies to treat various diseases. Its unique approach aims to harness the body's immune system for more effective treatments.